Michelle Bilski
Investor Relations, Insight Communications
Replay available
Solana Company (NASDAQ: HSDT) Q4 2023 earnings conference call, held 2024-03-28. Replay captured from the company's public earnings webcast.

Investor Relations, Insight Communications
President and Chief Executive Officer, Helios Medical Technologies, Inc.
Chief Financial Officer, Helios Medical Technologies, Inc.
Analyst, Roth MKM
Analyst, Ladenburg Thalman & Company
Analyst, Maxim Group
Good day, and thank you for standing by, and welcome to Helios Medical Technologies, Inc., Q4 2023 Earnings Conference Call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you'll need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Michelle Bilski, Insight Communications. Please go ahead. Thank you, operator. Welcome to the fourth quarter 2023 earnings conference call for Helios Medical Technologies. This is Michelle Bilski of Insight Communications, Investor Relations for Helios. With me on today's call are Dane Andrees, Helios Medical's President and Chief Executive Officer, and Jeff Mathieson, Chief Financial Officer. At this time, all participants have been placed in a listen-only mode. Please note that this call is being recorded and access to the webcast can be obtained through the investor section of the Helios website at www.heliosmedical.com. Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicating, including those identified in the risk factors section of our most recent annual report on Form 10-K. Such factors may be updated from time to time in our other filings with the SEC, which are available on our web...